David van de Vijver

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. pmc Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time
    Dineke Frentz
    Virology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
    PLoS ONE 5:e11505. 2010
  2. pmc Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention
    Ravindra K Gupta
    Division of Infection and Immunity, University College, 90 Gower St, London WC1E 6BT, UK
    Retrovirology 10:82. 2013
  3. pmc HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
    Ana B Abecasis
    Unidade de Saúde Pública Internacional e Bioestatística, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisboa, Portugal
    Retrovirology 10:7. 2013
  4. pmc Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients
    Kristof Theys
    Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium
    Retrovirology 9:81. 2012
  5. pmc Limited cross-border infections in patients newly diagnosed with HIV in Europe
    Dineke Frentz
    Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands
    Retrovirology 10:36. 2013
  6. doi request reprint Circulating HIV type 1 drug resistance will have limited impact on the effectiveness of preexposure prophylaxis among young women in Zimbabwe
    David A M C van de Vijver
    Department of Virology, Erasmus MC, University Medical Centre Rotterdam, The Netherlands
    J Infect Dis 199:1310-7. 2009
  7. doi request reprint The risk of HIV drug resistance following implementation of pre-exposure prophylaxis
    David A M C van de Vijver
    Department of Virology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
    Curr Opin Infect Dis 23:621-7. 2010
  8. pmc Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
    Dimitrios Paraskevis
    Katholieke Universiteit Leuven, Rega Institute for Medical Research, Minderbroederstraat 10, B 3000 Leuven, Belgium
    Retrovirology 6:49. 2009
  9. pmc Increasing risk behaviour can outweigh the benefits of antiretroviral drug treatment on the HIV incidence among men-having-sex-with-men in Amsterdam
    Shan Mei
    Information System and Management College, National University of Defense Technology, Changsha, China
    BMC Infect Dis 11:118. 2011
  10. doi request reprint Virological failure and drug resistance during first line anti-retroviral treatment in Indonesia
    Azzania Fibriani
    Department of Virology, Erasmus Medical Centre, Erasmus University, Rotterdam, The Netherlands
    J Med Virol 85:1394-401. 2013

Collaborators

Detail Information

Publications11

  1. pmc Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time
    Dineke Frentz
    Virology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
    PLoS ONE 5:e11505. 2010
    ..This study compares the ability of the most commonly used systems (ANRS, Rega, and Stanford's HIVdb) to predict virological outcome at 12, 24, and 48 weeks...
  2. pmc Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention
    Ravindra K Gupta
    Division of Infection and Immunity, University College, 90 Gower St, London WC1E 6BT, UK
    Retrovirology 10:82. 2013
    ....
  3. pmc HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
    Ana B Abecasis
    Unidade de Saúde Pública Internacional e Bioestatística, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisboa, Portugal
    Retrovirology 10:7. 2013
    ..Sequence variation may affect antiviral drug resistance development, disease progression, evolutionary rates and transmission routes...
  4. pmc Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients
    Kristof Theys
    Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium
    Retrovirology 9:81. 2012
    ....
  5. pmc Limited cross-border infections in patients newly diagnosed with HIV in Europe
    Dineke Frentz
    Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands
    Retrovirology 10:36. 2013
    ..In this study, phylogenetic associations among HIV of newly diagnosed patients were determined across Europe...
  6. doi request reprint Circulating HIV type 1 drug resistance will have limited impact on the effectiveness of preexposure prophylaxis among young women in Zimbabwe
    David A M C van de Vijver
    Department of Virology, Erasmus MC, University Medical Centre Rotterdam, The Netherlands
    J Infect Dis 199:1310-7. 2009
    ..Our objective was to predict whether PrEP, in the presence of circulating drug resistance, will reduce the risk of infection with HIV...
  7. doi request reprint The risk of HIV drug resistance following implementation of pre-exposure prophylaxis
    David A M C van de Vijver
    Department of Virology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
    Curr Opin Infect Dis 23:621-7. 2010
    ..Drug resistance could, therefore, be critical in the use of PrEP. We review the literature regarding risks associated with drug resistance owing to PrEP...
  8. pmc Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
    Dimitrios Paraskevis
    Katholieke Universiteit Leuven, Rega Institute for Medical Research, Minderbroederstraat 10, B 3000 Leuven, Belgium
    Retrovirology 6:49. 2009
    ..However the spatial diffusion of the epidemic from the perspective of the virus has not previously been traced...
  9. pmc Increasing risk behaviour can outweigh the benefits of antiretroviral drug treatment on the HIV incidence among men-having-sex-with-men in Amsterdam
    Shan Mei
    Information System and Management College, National University of Defense Technology, Changsha, China
    BMC Infect Dis 11:118. 2011
    ..Despite the era of potent antiretroviral therapy, the incidence of HIV among MSM increases. In the long term the contradictory effects of risk behavior and effective therapy are still poorly understood...
  10. doi request reprint Virological failure and drug resistance during first line anti-retroviral treatment in Indonesia
    Azzania Fibriani
    Department of Virology, Erasmus Medical Centre, Erasmus University, Rotterdam, The Netherlands
    J Med Virol 85:1394-401. 2013
    ..Patients in this cohort responded well to first line ART, with low rates of virological failure and drug resistance. A history of injecting drug use should not be a reason to withhold ART in this setting...
  11. pmc Patterns of transmitted HIV drug resistance in europe vary by risk group
    Dineke Frentz
    Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands
    PLoS ONE 9:e94495. 2014
    ..In Europe, a continuous programme (SPREAD) has been in place for ten years to study transmission of drug resistant HIV. We analysed time trends of transmitted drug resistance mutations (TDRM) in relation to the risk behaviour reported...